• Ananthu R
• Shobin B Varghese
• Abhirama B R
• Julia J J
• Prasobh G R

Propranolol is the first generation drug of β-blocker family, which is added in the medical utility for tachycardia and high blood pressure in the 1960s. However, the occasional discovery of propranolol within side the involution of infantile hemangiomas (IHs) delivered us a brand new perspective. IHs are the most common infantile tumor, affecting 4–10% newborns. So far, oral propranolol is the first-line remedy for IHs treatment. At the equal time, local injection and topical propranolol are developing. Despite the global utility, the specific mechanism of propranolol of IHs has now no longer been absolutely studied. In this article, we reviewed and summarized the modernfacts on pharmacology, mechanism, efficacy, and destructive outcomes of propranolol. Novel layout of biomaterials and bioactive molecules are wished for new remedy and best pathway to gain the minimum powerful treatment concentration and put off the destructive outcomes.

"A review on Infantile hemangiomas.", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.9, Issue 7, page no.c624-c640, July-2022, Available :http://www.jetir.org/papers/JETIR2207279.pdf

"A review on Infantile hemangiomas.", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.9, Issue 7, page no. ppc624-c640, July-2022, Available at : http://www.jetir.org/papers/JETIR2207279.pdf